Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells
Kim Anthony-Gonda, Alex Ray, Hang Su, et al.
JCI Insight (2022) Vol. 7, Iss. 21
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

CAR-T cell therapy: Where are we now, and where are we heading?
Jiayi Wang, Liang Wang
Blood Science (2023) Vol. 5, Iss. 4, pp. 237-248
Open Access | Times Cited: 22
Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells
Mayra A. Carrillo, Anjie Zhen, Wenli Mu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1000-1015
Open Access | Times Cited: 9
CAR-NK cell therapy: a potential antiviral platform
Ming-Hao Lin, Lijuan Hu, Jeffrey S. Miller, et al.
Science Bulletin (2025)
Closed Access
Optimal Chimeric Antigen Receptor (CAR)-mRNA for Transient CAR T Cell Generation
Reni Kitte, Robert Serfling, Ulrich Blache, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 965-965
Open Access
Application and Development of Gene Therapy in HIV-Treatment
Jiaqi Wang
Highlights in Science Engineering and Technology (2025) Vol. 129, pp. 33-41
Closed Access
Opportunities for CAR-T Cell Immunotherapy in HIV Cure
Gerard Campos-Gonzalez, Javier Martínez‐Picado, Talía Velasco-Hernández, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 789-789
Open Access | Times Cited: 13
Harnessing immune cells to eliminate HIV reservoirs
Paula Grasberger, Abigail R. Sondrini, Kiera Clayton
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 2, pp. 62-68
Open Access | Times Cited: 4
Generation of Anti-HIV CAR-T Cells for Preclinical Research
Hang Su, Kim Anthony-Gonda, Rimas J. Orentas, et al.
Methods in molecular biology (2024), pp. 287-298
Closed Access | Times Cited: 3
Eliminating the HIV tissue reservoir: current strategies and challenges
Kangpeng Li, Qiang Zhang
Infectious Diseases (2023) Vol. 56, Iss. 3, pp. 165-182
Closed Access | Times Cited: 8
Strategies to target the central nervous system HIV reservoir
Andrea Mastrángelo, Lúcio Gama, Paola Cinque
Current Opinion in HIV and AIDS (2024)
Closed Access | Times Cited: 2
The enchanting canvas of CAR technology: Unveiling its wonders in non-neoplastic diseases
Jinhui Shu, Wei Xie, Zhaozhao Chen, et al.
Med (2024) Vol. 5, Iss. 6, pp. 495-529
Open Access | Times Cited: 2
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV
P Rubinstein, Carlos Gálvez, Richard F. Ambinder
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 4, pp. 254-263
Closed Access | Times Cited: 2
Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure
Shuang Li, Hu Wang, Na Guo, et al.
Chinese Medical Journal (2023) Vol. 136, Iss. 22, pp. 2658-2667
Open Access | Times Cited: 6
Advancements in Cell-Based Therapies for HIV Cure
Yusuke Matsui, Yasuo Miura
Cells (2023) Vol. 13, Iss. 1, pp. 64-64
Open Access | Times Cited: 5
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission
Hang Su, April Mueller, Harris Goldstein
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 4, pp. 169-178
Closed Access | Times Cited: 1
Interventions during Early Infection: Opening a Window for an HIV Cure?
Christopher R. Hiner, April L. Mueller, Hang Su, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1588-1588
Open Access | Times Cited: 1
Engineering CAR-T therapies for autoimmune disease and beyond
Emily P. English, Robert Swingler, Simran Patwa, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 771
Open Access | Times Cited: 1
Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies
Amanda M. Buck, Tyler‐Marie Deveau, Timothy J. Henrich, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1126-1126
Open Access | Times Cited: 4
Efficient ex vivo expansion of conserved element vaccine-specific CD8+ T-cells from SHIV-infected, ART-suppressed nonhuman primates
Sandra Dross, Rasika Venkataraman, Shabnum Patel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination
Anne Galy, Ben Berkhout, Karine Breckpot, et al.
Human Gene Therapy (2023) Vol. 34, Iss. 17-18, pp. 896-904
Open Access | Times Cited: 2
CAR-T Therapy in HIV: Pioneering Advances and Navigating Challenges
Xiao Wang, Jianyang Liu, Feike Hao, et al.
Infectious Diseases & Immunity (2024) Vol. 4, Iss. 4, pp. 194-205
Open Access
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies
Wei Zhang, Miao Zeng, Yisheng Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Navigating the Roadblocks: Progress and Challenges in Cell‐Based Therapies for Human Immunodeficiency Virus
Lakshay Chhabra, Rajeev Kumar Pandey, Rajiv Kumar, et al.
Journal of Cellular Biochemistry (2024)
Closed Access
Rapamycin Enhances CAR-T Control of HIV Replication and Reservoir Elimination in vivo.
Wenli Mu, Shallu Tomer, Jeffrey Harding, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Stem cell-like memory T cells: Role in viral infections and autoimmunity
Meenakshi Sachdeva, Shivangi Taneja, Naresh Sachdeva
World Journal of Immunology (2023) Vol. 13, Iss. 2, pp. 11-22
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top